Holen Sie sich die Stockscreener-App
94.42
2.10%
-1.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$96.07
Offen:
$97.39
24-Stunden-Volumen:
1.24M
Relative Volume:
0.16
Marktkapitalisierung:
$120.75B
Einnahmen:
$407.94B
Nettoeinkommen (Verlust:
$2.90B
KGV:
41.47
EPS:
2.2771
Netto-Cashflow:
$7.39B
1W Leistung:
-3.27%
1M Leistung:
-1.72%
6M Leistung:
+20.18%
1J Leistung:
+31.09%
1-Tages-Spanne:
$92.79
$97.98
1-Wochen-Bereich:
$92.79
$98.07
52-Wochen-Spanne:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
94.42 | 122.87B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
384.37 | 359.79B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
397.26 | 87.17B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.77 | 72.89B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
394.52 | 48.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Bernstein raises CVS Health stock price target on faster Aetna turnaround - Investing.com Canada
CVS Health marks 20 years of Project Health free screenings - CVS Health
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CVS Health Corp. stock gains on strong Q2 2026 earnings beat - AD HOC NEWS
Wall Street Loves CVS Health Stock Right Now. Should You? - Yahoo Finance
CVS Health (CVS) Launches Updated 2026 2027 COVID 19 Vaccines Nationwide - simplywall.st
Back-to-School Health Checklist: What Parents Can Do To Help Kids Start the School Year Strong - ACCESS Newswire
What Is Putting CVS Health Stock in Focus? (NYSE:CVS) - Kalkine Media
What Women Want From Weight Management Support, and Why It Matters - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-09-08 - TradingView
CVS Health Corp stock gains as margin repair at Aetna boosts outlook - AD HOC NEWS
Groupe la Francaise Takes $5.17 Million Position in CVS Health Corporation $CVS - MarketBeat
California State Teachers Retirement System Has $20 Billion Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Continuum Advisory LLC - MarketBeat
CVS Health Corp stock holds steady as investors digest strong earnings and outlook - AD HOC NEWS
Here's How CVS Is Focusing on Aetna's Profitability Turnaround - Yahoo Finance
CVS Health Corporation $CVS Shares Purchased by Amundi - MarketBeat
Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey - ACCESS Newswire
CVS Health signs on as official partner of professional volleyball league - Providence Business News
CVS Health (CVS) Stock Looks Below Fair Value But Mixed After 65% Return - Yahoo Finance
Saudi Central Bank Buys 42,199 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health stock gains as vaccines and Q2 beat support it - AD HOC NEWS
Azimuth Capital Investment Management LLC Raises Stock Position in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum - Yahoo Finance
Munich Reinsurance Co Stock Corp in Munich Takes $47.53 Million Position in CVS Health Corporation $CVS - MarketBeat
NEOS Investment Management LLC Raises Holdings in CVS Health Corporation $CVS - MarketBeat
Concurrent Investment Advisors LLC Grows Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Is CVS Health Outperforming the Nasdaq? - Yahoo Finance
TD Waterhouse Canada Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
CVS Escapes Customer's Generic Mucinex Benzene Suit - Law360
Why Is CVS Health (NYSE:CVS) Drawing Fresh Attention in Value Stocks? - Kalkine Media
CVS Health Corp. stock gains on UBS buy rating and raised revenue outlook - AD HOC NEWS
Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S. - CVS Health
Most insured patients can get updated COVID vaccines at CVS for no cost - Stock Titan
Mapping vertical integration in US health insurance - brookings.edu
CVS Health Corp (N: CVS) Share Price, CVS Stock News, CVS Share Price & Updates - Kalkine
CVS Stock Has Left Its Peers Behind. Or Has It? - Trefis
Nykredit A S Purchases New Position in CVS Health Corporation $CVS - MarketBeat
B. Metzler seel. Sohn & Co. AG Boosts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
LOVB Announces CVS Pharmacy as an Official Health & Wellness Partner - Yahoo Finance
Bill Ackman Backs Mark Cuban's Drug Pricing ModelHumana (NYSE:HUM) - benzinga.com
Nan Shan Life Insurance Co. Ltd. Reduces Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp (CVS) Stock Up 3.9% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
CVS Health (NYSE:CVS) Strengthens Full-Year View As Aetna Rebounds - Kalkine Media
What women want from weight management support, and why it matters - CVS Health
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Corp Stock (CVS) Moved Up by 3.29% on Sep 1: Facts Behind the Movement - tradingkey.com
Why CVS Stock Rallied Tuesday Morning - Yahoo Finance
Why Is CVS Health Stock in Focus? (NYSE:CVS) - Kalkine Media
Why CVS Health (CVS) Stock Is Up Today - Quiver Quantitative
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):